Content
All Posts > Content under Healthcare
Packaged-Goods Companies Slash Marketing Spending As Amazon Makes Sales "All About Price"
Article By:
Tyler Durden
Read
Tuesday, July 11, 2017 5:46 AM EDT
Amazon’s dominance of all things retail-related in the US is starting to effect on how packaged goods are marketed: Big Brands are starting to give up on expensive advertising campaigns because customers no longer see the value in expert branding.
Pieris Pharmaceutical - Chart Of The Day
Article By:
Jim Van Meerten
Read
Monday, July 10, 2017 6:51 PM EDT
Since the Trend Spotter signaled a buy in 5/4 the stock gained 67.51%.
In this article: PIRS
Week In Review: Beigene Sets Record With $1.4 Billion Celgene Deal
Article By:
ChinaBio® Today
Read
Saturday, July 8, 2017 2:35 PM EDT
BeiGene of Beijing has entered a "transformational" collaboration with Celgene which involves BeiGene's clinical-stage PD-1 immuno-oncology drug, has a total value of almost $1.4 billion.
Celsion Corporation Announces $5 Million Registered Direct Offering
Article By:
NASDAQ GlobeNewswire
Read
Thursday, July 6, 2017 12:28 PM EDT
Celsion Corporation today announced that it has entered into definitive agreements with several institutional investors to purchase an aggregate of approximately $5 million of shares of common stock.
In this article: CLSN
How To Generate A 10% Return In 45 Days
Article By:
Greg Group
Read
Thursday, July 6, 2017 6:18 AM EDT
ALKS has formed a pattern called Flag (Bullish), providing a target price for the short-term in the range of 61.50 to 62.30. We think the stock can hit the target price within 6 weeks or less.
In this article: ALKS
Charles River Labs - Chart Of The Day
Article By:
Jim Van Meerten
Read
Wednesday, July 5, 2017 5:45 PM EDT
Revenue expected to grow 8.90% this year and another 6.70% next year.
In this article: CRL
4 High Earnings Yield Stocks To Boost Your Portfolio
Article By:
Zacks Investment Research
Read
Wednesday, July 5, 2017 12:35 PM EDT
Earnings yield is an easy but useful ratio for investors putting their money into stocks or bonds. It is the reciprocal of the price-to-earnings (P/E) ratio and used to spot undervalued stocks.
Anika Therapeutics Offers A Long-Term Growth Opportunity With Robust Pipeline
Article By:
KKD Healthcare Analytics
Read
Wednesday, July 5, 2017 10:43 AM EDT
Anika Therapeutics has relatively mild risk profile. The company has established products in the market while its drug candidates have high probability of receiving the FDA approval as well as of performing well in the market.
In this article: ANIK
Intuitive Surgical Price Target Raised To $1,080 From $850 At Leerink
Article By:
The Fly
Read
Wednesday, July 5, 2017 9:30 AM EDT
Leerink analyst Richard Newitter raised his price target for Intuitive Surgical shares to $1,080 and reiterates an Outperform rating on the shares. The maker of da Vinci Surgical Systems closed Monday down $13.71 to $921.66.
In this article: ISRG